<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Markedly increased esophageal eosinophils are associated with <z:e sem="disease" ids="C0869403,C0700625,C0020517" disease_type="Pathologic Function;Disease or Syndrome" abbrv="">allergy</z:e>- or reflux-based eosinophilic <z:hpo ids='HP_0100633'>esophagitis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Other known disorders that cause this entity are unusual </plain></SENT>
<SENT sid="2" pm="."><plain>To characterize the clinical, endoscopic, and histological findings of patients who develop marked esophageal eosinophilic infiltration after ablative therapy for Barrett's <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients who underwent endoscopic ablation of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> between 1991 and 2009 with photodynamic therapy or radio frequency were screened for a pathologic descriptor of 'eosinophils' on biopsy </plain></SENT>
<SENT sid="4" pm="."><plain>Patients whose biopsies demonstrated &gt;15 eosinophils per high power (HPF) field in squamous epithelium after ablation were reviewed and included in the study group </plain></SENT>
<SENT sid="5" pm="."><plain>Thirteen of 385 (3.4%) patients underwent ablation for <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and subsequently had large numbers of intraepithelial eosinophils </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients had long segment Barrett's (mean 8.0 cm) with low- or high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> had undergone photodynamic therapy as their form of ablation </plain></SENT>
<SENT sid="8" pm="."><plain>No patients had typical symptoms or endoscopic findings of eosinophilic <z:hpo ids='HP_0100633'>esophagitis</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Eleven patients were on <z:chebi fb="0" ids="49200">proton pump inhibitors</z:chebi> </plain></SENT>
<SENT sid="10" pm="."><plain>The time between ablation and <z:hpo ids='HP_0003674'>onset</z:hpo> of esophageal <z:hpo ids='HP_0001880'>eosinophilia</z:hpo> ranged from 83 to 692 days </plain></SENT>
<SENT sid="11" pm="."><plain>Intraepithelial eosinophil counts ranged from 30 to 150/HPF (mean 90) </plain></SENT>
<SENT sid="12" pm="."><plain>The majority of cases showed eosinophilic degranulation, spongiosis, increased papillary height, and basal zone thickening </plain></SENT>
<SENT sid="13" pm="."><plain>The natural history of esophageal <z:hpo ids='HP_0001880'>eosinophilia</z:hpo> was variable after ablation, persisting consistently or sporadically on biopsy for up to 6 years </plain></SENT>
<SENT sid="14" pm="."><plain>Ablation for Barrett's <z:mpath ids='MPATH_589'>dysplasia</z:mpath> can be followed rarely by eosinophil infiltrates with a histological resemblance to <z:e sem="disease" ids="C0869403,C0700625,C0020517" disease_type="Pathologic Function;Disease or Syndrome" abbrv="">allergy</z:e>-based eosinophilic <z:hpo ids='HP_0100633'>esophagitis</z:hpo>, but lacking <z:hpo ids='HP_0002015'>dysphagia</z:hpo> </plain></SENT>
<SENT sid="15" pm="."><plain>The pathophysiology is unknown </plain></SENT>
</text></document>